As of 30 Sep 2025, 1 institutional investors reported holding $1,846,000 in principal (par value) of Medline Borrower LP - Corporate Bond - Domestic.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $1,846,000 | $1,779,770 | -$206,317 | 96.41% | 1 |
| 2025 Q2 | $2,060,000 | $1,977,166 | +$261,463 | 95.98% | 1 |
| 2025 Q1 | $1,835,000 | $1,715,728 | -$345,015 | 93.5% | 1 |
| 2024 Q4 | $2,204,000 | $2,041,667 | +$620,315 | 92.63% | 1 |
| 2024 Q3 | $1,500,000 | $1,421,321 | -$531,548 | 94.75% | 1 |
| 2024 Q2 | $2,061,000 | $1,898,475 | -$275,409 | 92.11% | 1 |
| 2024 Q1 | $2,360,000 | $2,150,401 | +$879,308 | 91.12% | 1 |
| 2023 Q4 | $1,395,000 | $1,262,581 | $0 | 90.51% | 1 |
| 2023 Q3 | $1,395,000 | $1,179,783 | -$105,713 | 84.57% | 1 |
| 2023 Q2 | $1,520,000 | $1,318,080 | +$884,544 | 86.72% | 1 |
| 2023 Q1 | $500,000 | $433,795 | -$981,256 | 86.76% | 1 |
| 2022 Q4 | $1,631,000 | $1,315,671 | +$351,721 | 80.67% | 1 |
| 2022 Q3 | $1,195,000 | $961,000 | +$293,533 | 80.42% | 1 |
| 2022 Q2 | $830,000 | $711,000 | -$389,753 | 85.66% | 1 |
| 2022 Q1 | $1,285,000 | $1,189,000 | -$1,392,577 | 92.53% | 1 |
| 2021 Q4 | $2,790,000 | $2,786,000 | +$2,786,094 | 99.86% | 1 |